James Jones - 02 Dec 2024 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
James Jones by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
02 Dec 2024
Net transactions value
+$1,318
Form type
4
Filing time
30 Dec 2024, 19:45:42 UTC
Previous filing
05 Dec 2024
Next filing
04 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $93.1 +70 +0.18% $1.33 39,447 02 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $88.2 +70 +0.18% $1.26 39,517 03 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $85.4 +70 +0.18% $1.22 39,587 04 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $78 +65 +0.16% $1.20 39,652 05 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $84 +70 +0.18% $1.20 39,722 06 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $87.5 +70 +0.18% $1.25 39,792 09 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $79.36 +32 +0.08% $2.48 39,824 10 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $73.28 +32 +0.08% $2.29 39,856 11 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $70.08 +32 +0.08% $2.19 39,888 12 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $74.56 +32 +0.08% $2.33 39,920 13 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $108 +49 +0.12% $2.21 39,969 16 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $104 +49 +0.12% $2.12 40,018 17 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $107 +49 +0.12% $2.19 40,067 18 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $93.2 +40 +0.1% $2.33 40,107 19 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $91.65 +39 +0.1% $2.35 40,146 20 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.